Yes, though not in the way most people assume. Vitamin D does not make a healthy immune system stronger. It acts as a regulator: immune cells carry vitamin D receptors and produce the active form themselves when they encounter a threat, using the vitamin D circulating in your blood as raw material. When that supply runs low, the response is measurably less well controlled.
I recently had the chance to meet Dr. Ute-Christiane Meier, and then spent a while reading through her work. It is genuinely fascinating. She is a neuroimmunologist at LMU München who did her doctorate at Oxford, spent 13 years leading neuroinflammation research at Queen Mary University of London, and holds patents on using vitamin D alongside inflammatory markers to measure immune activation. Almost everything you read about vitamin D and immunity stops at "it supports your immune system." Her work is about what that sentence actually means. Her commentary runs through this piece.
Key takeaways
- Most immune cells carry the vitamin D receptor, including T cells, B cells, macrophages and dendritic cells.
- Those cells also carry the enzyme that converts stored vitamin D into its active form, so they activate it locally rather than waiting for the kidney.
- The effect is regulatory. It turns inflammatory signalling down and antimicrobial defence up at the same time.
- Across 25 randomised trials in 11,321 people, supplementation reduced the odds of at least one acute respiratory infection by roughly 12%.
- That benefit was concentrated almost entirely in people who were low to begin with, and in those taking it daily or weekly rather than in occasional large doses.
- Vitamin D trials are unusually hard to run, which explains much of why published results look inconsistent.
What does vitamin D actually do to immune cells?
The vitamin D receptor is not confined to bone and gut tissue. It is expressed across the immune system: on T cells, B cells, monocytes, macrophages and dendritic cells. When active vitamin D binds that receptor, it changes which genes those cells switch on.
The direction of the change is consistent. Inflammatory signalling goes down, particularly the Th1 and Th17 pathways that drive tissue-damaging responses. Regulatory signalling goes up, including regulatory T cells and IL-10, the cytokine that tells an immune response when to stop. Dendritic cells shift toward a more tolerant state.
At the same time, the innate side goes up rather than down. Active vitamin D switches on genes for antimicrobial peptides, principally cathelicidin, which physically disrupt bacterial membranes.
Which is why "boost" kept bothering me as a word. I asked Dr. Meier about it.
"An immune response that is too strong can be just as problematic as one that is too weak. Rather than simply boosting immunity, vitamin D appears to fine-tune the immune system, helping to orchestrate effective responses to pathogens while preventing excessive, potentially harmful inflammation."
— Dr. Ute-Christiane Meier, neuroimmunologist, LMU München
Why do immune cells make their own vitamin D?
This is the part that changed how I read a blood test result.
Vitamin D from sun or supplements is not active. The liver converts it into 25-hydroxyvitamin D, the storage form, which is what a blood test measures. Conventionally, the kidney then converts that into the active hormone and releases it into circulation.
Immune cells bypass that. They carry CYP27B1, the same activating enzyme, and switch it on themselves.
The landmark demonstration came in 2006. Researchers showed that when a human macrophage detects a bacterial pattern through a Toll-like receptor, it responds by increasing both the vitamin D receptor and the activating enzyme, then produces cathelicidin and kills the bacteria inside it. Crucially, the effect depended on the vitamin D available in the surrounding serum. Serum from donors with low 25-hydroxyvitamin D was inefficient at supporting the response. The study was published in Science.
The immune cell does the activation. The circulating level is the raw material it draws on.
So the storage form measured in blood matters even though it is biologically inert. It is the supply line. A macrophage that detects a pathogen and finds nothing to convert cannot mount the same response.
Dr. Meier told me how that finding landed at the time, and where the open questions sit now.
"The discovery that vitamin D induces antimicrobial peptides as part of the body's defense mechanisms was fascinating and took the scientific community by surprise. Equally intriguing was the finding that some viruses can interfere with vitamin D receptor signaling. We are only just beginning to understand the broader role of vitamin D in anti-pathogen immunity, including its potential influence on the composition and function of the gut microbiome."
— Dr. Ute-Christiane Meier
Does taking vitamin D reduce how often you get sick?
Here the evidence is real but more modest than the mechanism might suggest, and I want to be precise about it.
The most rigorous analysis pooled individual data from 25 randomised, double-blind, placebo-controlled trials covering 11,321 people aged 0 to 95. Supplementation reduced the odds of experiencing at least one acute respiratory tract infection by about 12%. Overall, 33 people needed to take vitamin D to prevent one infection. The analysis was published in the BMJ in 2017.
A 12% reduction across everyone is not dramatic. But the average conceals the finding that actually matters.
Why does it seem to work for some people and not others?
Two things separated the people who benefited from the people who did not.
Starting level. The protective effect was concentrated in participants who were low on vitamin D at baseline. In people who already had adequate levels, adding more did very little.
Dosing pattern. Daily or weekly supplementation worked. Occasional large bolus doses did not. Among people taking it daily or weekly, the number needed to prevent one infection dropped from 33 to 20.
| Factor | What the trial data showed |
|---|---|
| Everyone pooled | Roughly 12% lower odds of at least one infection |
| People low at baseline | Where the effect was concentrated |
| Already sufficient | Little additional benefit |
| Daily or weekly dosing | 1 infection prevented per 20 people |
| Intermittent large doses | No clear benefit |
Both findings fit the biology. If immune cells draw on circulating vitamin D as they need it, then a steady supply is what matters, and topping up someone who already has enough should not change much.
Why are vitamin D studies so hard to interpret?
This was the question I most wanted answered. The mechanism is well established, so why does the trial literature look so mixed? Dr. Meier has run these studies, and her answer is that vitamin D is unusually difficult to study in the first place.
"Vitamin D trials are particularly challenging to conduct. We were involved in a large European study across several countries in which we assessed vitamin D status. Just imagine the potential bias if you measured vitamin D levels in Sweden during winter and compared them with blood samples collected in Italy during summer."
"Sun exposure is extremely difficult to control for and is influenced by numerous factors, including latitude, season, time spent outdoors, clothing, skin pigmentation, and even air pollution. In addition, vitamin D metabolism is affected by factors such as body weight, age, medication use, and genetic variation."
"All of these factors can substantially influence vitamin D status, making it difficult to disentangle the effects of an intervention from the many other determinants of vitamin D levels."
— Dr. Ute-Christiane Meier
This is worth sitting with, because it reframes how to read any individual headline about vitamin D. A trial that finds no effect may have enrolled people who were already replete, or dosed intermittently, or run across seasons and latitudes that swamped the intervention. None of that means the underlying biology is wrong. It means the question is harder to ask cleanly than it looks.
Is there a link between vitamin D and inflammation?
Beyond infection, there is a body of work on the relationship between vitamin D status and markers of ongoing low-grade inflammation. This is the part of Dr. Meier's research I found most interesting.
Take matrix metalloproteinase-9, an enzyme involved in tissue remodelling and in inflammatory processes across a range of conditions. She and her colleagues found that circulating 25-hydroxyvitamin D correlated inversely with MMP-9. Lower vitamin D, higher MMP-9. That relationship is the basis of patents she holds in the United States and Europe covering the measurement of vitamin D alongside inflammatory markers as a combined signal of immune activation.
Which raises an obvious question. Does low vitamin D drive that inflammation, or does an activated immune system burn through vitamin D faster? It is genuinely unsettled, and it is the subject of a later article in this series.
How much vitamin D do you need?
There is no separate "immune dose." There is your level, and whether it is adequate.
Around 70% of American adults have levels below the range generally considered sufficient, which is why the trial finding about baseline status is relevant to so many people. If you want to know where you stand, a 25-hydroxyvitamin D blood test is inexpensive and your doctor can order it.
For maintaining a level rather than correcting one, the practical points from the evidence are consistency and steady daily intake. Vitamin D is fat soluble, so it absorbs better taken with fat. More on daily amounts here, and the signs of running low here.
D3X was built around that principle: 2,000 IU of D3 with 100 mcg of K2 in an organic olive oil base, taken daily, which supports normal immune function.*
Sources
- Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 2006;311:1770-1773.
- Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ, 2017;356:i6583.
- Jolliffe DA, Camargo CA, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes & Endocrinology, 2021;9:276-292.
- Meier U-C, Ramagopalan S, Müller N. Environmental risk factors and inflammation in psychiatric and neurological disease. Frontiers in Psychiatry, 2022.
Last updated: September 2026
About the reviewer. PD Dr. Ute-Christiane Meier is a neuroimmunologist and viral immunologist at Ludwig-Maximilians-Universität München. She completed her doctorate at the University of Oxford and worked there for 16 years in viral immunology and vaccine research, then spent 13 years leading neuroinflammation and psychoimmunology research at the Blizard Institute, Queen Mary University of London. She serves on the World Psychiatric Association's steering committee for immunopsychiatry and holds patents in the US and Europe on the use of vitamin D alongside inflammatory markers as a measure of low-grade inflammation. She receives no compensation from D3X.
About D3X. D3X makes one thing: a clean liquid vitamin D3 + K2 (2,000 IU D3 / 100 mcg K2) in an olive-oil base, third-party tested and made in the USA. No seed oils, fillers, or sweeteners. Learn more →
Frequently Asked
Does vitamin D actually help your immune system?
Immune cells including T cells, macrophages and dendritic cells carry vitamin D receptors, and vitamin D influences which genes those cells switch on. The effect is regulatory rather than stimulating: it turns inflammatory signalling down while turning antimicrobial defence up.*
How does vitamin D fight infection?
When a macrophage detects a bacterial pattern, it increases both the vitamin D receptor and the enzyme that activates vitamin D, then produces cathelicidin, an antimicrobial peptide that disrupts bacterial membranes. This was demonstrated in a 2006 study published in Science.
Does taking vitamin D stop you getting colds?
A pooled analysis of 25 randomised trials in 11,321 people found supplementation reduced the odds of at least one acute respiratory infection by around 12%. The benefit was concentrated in people who were low on vitamin D beforehand and in those taking it daily or weekly rather than in occasional large doses.
Why do vitamin D studies show different results?
Two factors explain much of the variation: starting level and dosing pattern. Trials in people who already had adequate vitamin D found little effect, and trials using large intermittent doses performed worse than those using daily or weekly dosing.
Why are vitamin D studies so hard to interpret?
Sun exposure is very difficult to control for, and is affected by latitude, season, time spent outdoors, clothing, skin pigmentation and air pollution. Vitamin D metabolism also varies with body weight, age, medication use and genetics. According to neuroimmunologist Dr. Ute-Christiane Meier, these factors make it hard to separate the effect of an intervention from the many other things determining a person's vitamin D level.
How much vitamin D do you need for immune function?
There is no separate immune dose. What matters is whether your level is adequate, which a 25-hydroxyvitamin D blood test will tell you. Because vitamin D is fat soluble, taking it with a meal containing fat improves absorption.*
